Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c
Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.